Detalles de la búsqueda
1.
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
BMC Cancer
; 22(1): 915, 2022 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999527
2.
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Oncologist
; 26(10): e1854-e1861, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101934
3.
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
Br J Cancer
; 119(11): 1326-1331, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30405211
4.
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach.
Crit Rev Oncol Hematol
; 199: 104247, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307393
5.
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Sci Rep
; 13(1): 1257, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690734
6.
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Eur J Cancer
; 155: 56-63, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358777
7.
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study.
Clin Sarcoma Res
; 3(1): 16, 2013 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-24345066
Resultados
1 -
7
de 7
1
Próxima >
>>